Literature DB >> 20558822

Impact of combined deficiency of hepatic lipase and endothelial lipase on the metabolism of both high-density lipoproteins and apolipoprotein B-containing lipoproteins.

Robert J Brown1, William R Lagor, Sandhya Sankaranaravanan, Tomoyuki Yasuda, Thomas Quertermous, George H Rothblat, Daniel J Rader.   

Abstract

RATIONALE: Hepatic lipase (HL) and endothelial lipase (EL) are extracellular lipases that both hydrolyze triglycerides and phospholipids and display potentially overlapping or complementary roles in lipoprotein metabolism.
OBJECTIVE: We sought to dissect the overlapping roles of HL and EL by generating mice deficient in both HL and EL (HL/EL-dko) for comparison with single HL-knockout (ko) and EL-ko mice, as well as wild-type mice. METHODS AND
RESULTS: Reproduction and viability of the HL/EL-dko mice were impaired compared with the single-knockout mice. The plasma levels of total cholesterol, high-density lipoprotein (HDL) cholesterol, non-HDL cholesterol, and phospholipids in the HL/EL-dko mice were markedly higher than those in the single-knockout mice. Most notably, the HL/EL-dko mice exhibited an unexpected substantial increase in small low-density lipoproteins. Kinetic studies with [(3)H]cholesteryl ether-labeled very-low-density lipoproteins demonstrated that the HL/EL-dko mice accumulated counts in the smallest low-density lipoprotein-sized fractions, as assessed by size exclusion chromatography, suggesting that it arises from lipolysis of very-low-density lipoproteins. HDL from all 3 lipase knockout models had an increased cholesterol efflux capacity but reduced clearance of HDL cholesteryl esters versus control mice. Despite their higher HDL cholesterol levels, neither HL-ko, EL-ko, nor HL/EL-dko mice demonstrated an increased rate of macrophage reverse cholesterol transport in vivo.
CONCLUSIONS: These studies reveal an additive effect of HL and EL on HDL metabolism but not macrophage reverse cholesterol transport in mice and an unexpected redundant role of HL and EL in apolipoprotein B lipoprotein metabolism.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20558822      PMCID: PMC2948973          DOI: 10.1161/CIRCRESAHA.110.219188

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  46 in total

1.  Hepatic lipase mediates the uptake of chylomicrons and beta-VLDL into cells via the LDL receptor-related protein (LRP).

Authors:  A Krapp; S Ahle; S Kersting; Y Hua; K Kneser; M Nielsen; J Gliemann; U Beisiegel
Journal:  J Lipid Res       Date:  1996-05       Impact factor: 5.922

2.  Hepatic lipase deficiency increases plasma cholesterol but reduces susceptibility to atherosclerosis in apolipoprotein E-deficient mice.

Authors:  H Mezdour; R Jones; C Dengremont; G Castro; N Maeda
Journal:  J Biol Chem       Date:  1997-05-23       Impact factor: 5.157

3.  Overexpression of hepatic lipase in transgenic mice decreases apolipoprotein B-containing and high density lipoproteins. Evidence that hepatic lipase acts as a ligand for lipoprotein uptake.

Authors:  H L Dichek; W Brecht; J Fan; Z S Ji; S P McCormick; H Akeefe; L Conzo; D A Sanan; K H Weisgraber; S G Young; J M Taylor; R W Mahley
Journal:  J Biol Chem       Date:  1998-01-23       Impact factor: 5.157

4.  Hepatic lipase gene polymorphisms influence plasma HDL levels. Results from Finnish EARS participants. European Atherosclerosis Research Study.

Authors:  S Murtomäki; E Tahvanainen; M Antikainen; L Tiret; V Nicaud; H Jansen; C Ehnholm
Journal:  Arterioscler Thromb Vasc Biol       Date:  1997-10       Impact factor: 8.311

5.  Heparan sulfate proteoglycans participate in hepatic lipaseand apolipoprotein E-mediated binding and uptake of plasma lipoproteins, including high density lipoproteins.

Authors:  Z S Ji; H L Dichek; R D Miranda; R W Mahley
Journal:  J Biol Chem       Date:  1997-12-12       Impact factor: 5.157

6.  A hepatic lipase (LIPC) allele associated with high plasma concentrations of high density lipoprotein cholesterol.

Authors:  R Guerra; J Wang; S M Grundy; J C Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-29       Impact factor: 11.205

7.  Hepatic lipase gene therapy in hepatic lipase-deficient mice. Adenovirus-mediated replacement of a lipolytic enzyme to the vascular endothelium.

Authors:  D Applebaum-Bowden; J Kobayashi; V S Kashyap; D R Brown; A Berard; S Meyn; C Parrott; N Maeda; R Shamburek; H B Brewer; S Santamarina-Fojo
Journal:  J Clin Invest       Date:  1996-02-01       Impact factor: 14.808

8.  Common variants in the promoter of the hepatic lipase gene are associated with lower levels of hepatic lipase activity, buoyant LDL, and higher HDL2 cholesterol.

Authors:  A Zambon; S S Deeb; J E Hokanson; B G Brown; J D Brunzell
Journal:  Arterioscler Thromb Vasc Biol       Date:  1998-11       Impact factor: 8.311

9.  Hepatic lipase affects both HDL and ApoB-containing lipoprotein levels in the mouse.

Authors:  S Braschi; N Couture; A Gambarotta; B R Gauthier; C R Coffill; D L Sparks; N Maeda; J R Schultz
Journal:  Biochim Biophys Acta       Date:  1998-06-15

10.  A naturally occurring variant of endothelial lipase associated with elevated HDL exhibits impaired synthesis.

Authors:  Robert J Brown; Andrew C Edmondson; Nathalie Griffon; Theophelus B Hill; Ilia V Fuki; Karen O Badellino; Mingyao Li; Megan L Wolfe; Muredach P Reilly; Daniel J Rader
Journal:  J Lipid Res       Date:  2009-05-03       Impact factor: 5.922

View more
  27 in total

1.  Aerobic exercise reduces triglycerides by targeting apolipoprotein C3 in patients with coronary heart disease.

Authors:  Yating Wang; Li Shen; Danyan Xu
Journal:  Clin Cardiol       Date:  2018-12-21       Impact factor: 2.882

Review 2.  Lipase maturation factor 1: a lipase chaperone involved in lipid metabolism.

Authors:  Miklós Péterfy
Journal:  Biochim Biophys Acta       Date:  2011-10-12

Review 3.  Novel HDL-directed pharmacotherapeutic strategies.

Authors:  Emil M Degoma; Daniel J Rader
Journal:  Nat Rev Cardiol       Date:  2011-01-18       Impact factor: 32.419

4.  Lipase maturation factor 1 is required for endothelial lipase activity.

Authors:  Osnat Ben-Zeev; Maryam Hosseini; Ching-Mei Lai; Nicole Ehrhardt; Howard Wong; Angelo B Cefalù; Davide Noto; Maurizio R Averna; Mark H Doolittle; Miklós Péterfy
Journal:  J Lipid Res       Date:  2011-03-28       Impact factor: 5.922

5.  Exploration of Serum Marker Proteins in Mice Induced by Babesia microti Infection Using a Quantitative Proteomic Approach.

Authors:  Xiaoshuang Wang; Shuguang Ren; Xiaohong Yang; Abolfazl Masoudi; Xiaomin Xue; Mengxue Li; Hongxia Li; Xiaojing Zhang; Hui Wang; Jingze Liu
Journal:  Protein J       Date:  2021-01-02       Impact factor: 2.371

6.  Overexpression and deletion of phospholipid transfer protein reduce HDL mass and cholesterol efflux capacity but not macrophage reverse cholesterol transport.

Authors:  Takashi Kuwano; Xin Bi; Eleonora Cipollari; Tomoyuki Yasuda; William R Lagor; Hannah J Szapary; Junichiro Tohyama; John S Millar; Jeffrey T Billheimer; Nicholas N Lyssenko; Daniel J Rader
Journal:  J Lipid Res       Date:  2017-01-30       Impact factor: 5.922

7.  PK/PD Disconnect Observed with a Reversible Endothelial Lipase Inhibitor.

Authors:  Jon J Hangeland; Lynn M Abell; Leonard P Adam; Ji Jiang; Todd J Friends; Lauren E Haque; James Neels; Joelle M Onorato; Alice Ye A Chen; David S Taylor; Xiaohong Yin; Thomas W Harrity; Michael D Basso; Richard Yang; Paul G Sleph; David A Gordon; Christine S Huang; Ruth R Wexler; Heather J Finlay; R Michael Lawrence
Journal:  ACS Med Chem Lett       Date:  2018-06-15       Impact factor: 4.345

8.  Lipidomic analyses of female mice lacking hepatic lipase and endothelial lipase indicate selective modulation of plasma lipid species.

Authors:  Yanbo Yang; Takashi Kuwano; William R Lagor; Carolyn J Albert; Siobhan Brenton; Daniel J Rader; David A Ford; Robert J Brown
Journal:  Lipids       Date:  2014-04-29       Impact factor: 1.880

Review 9.  Biochemistry and pathophysiology of intravascular and intracellular lipolysis.

Authors:  Stephen G Young; Rudolf Zechner
Journal:  Genes Dev       Date:  2013-03-01       Impact factor: 11.361

10.  Lycopene stabilizes lipoprotein levels during D-galactosamine/lipopolysaccharide induced hepatitis in experimental rats.

Authors:  Sheik Abdulazeez Sheriff; Thiruvengadam Devaki
Journal:  Asian Pac J Trop Biomed       Date:  2012-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.